The number of U.S. Latinos with the memory-robbing disease is expected to rise more than eightfold by 2060 to 3.5 million.
Se espera que el número de latinos con la enfermedad roba-memoria aumente más de 8 veces para 2060, a 3.5 millones.
Most veterans who commit suicide do so with a gun, but most therapists don’t understand gun culture. A veteran who has struggled with depression himself now helps bridge that gap by educating mental health professionals.
Rep. Chris Collins’ enthusiastic investments in Australian biotech company Innate Immunotherapeutics preceded share purchases by the Buffalo Republican’s family members, associates and political donors — raising questions from Washington, D.C., to Sydney.
People earning low wages are more likely than those with higher incomes to go to an emergency room or be admitted to the hospital for avoidable conditions, a study in Health Affairs finds.
A Republican-led effort to overturn D.C.’s aid-in-dying law may catalyze a broader effort to ban the practice nationally.
A drug from Marathon Pharmaceuticals has ignited a firestorm on Capitol Hill and beyond. What makes it different than the $750,000 drug that came before it?
One in four doctors practicing in the U.S. is an international medical doctor. Many foreign-born doctors practice in parts of the country where there are doctor shortages.
The state has one of the highest rates of small business owners who get health coverage through the Affordable Care Act.
A study shows some emergency physicians wrote far more opioid prescriptions and Medicare patients who saw those doctors were more likely to still be taking the addictive painkillers months later.
The Trump administration’s first health regulation would shorten the enrollment periods and make it harder for patients to get coverage outside of that annual signup period.
People who do not get insurance through their job or the government have long battled a difficult market.
The federal program paid $16 million in the first six months of 2016 to counsel 223,000 patients about treatment preferences in their last days.
As conservative physicians rise to more powerful positions in government, some question whether they speak for the nation’s doctors.
The president says Obamacare has been “a complete and total disaster,” and other Republicans see nothing but trouble. But a careful look at the arguments suggest the situation is more complicated.
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
A federal judge in Texas last month issued a preliminary injunction barring the government from enforcing a rule allowing insurers to refuse to insure dialysis patients who get premium assistance from charity groups.
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
Taking time to discuss the inevitable can help conquer a universal fear.
More than 6,000 workers had levels in their blood that could lead to heart, kidney or cognitive disease, according to state findings.